Showing results (1161-1170 of 4,798) with videos related to

Sort By:
Pageof 480
Cephalalgia : an International Journal of Headache|June 17, 2026
Methodological limitations of anxiety screening tools used in migraine studies -a narrative reviewMonica Yen Hoang Pham, Jasmin Asheer, Fatima Ali, et al.
Cephalalgia : an International Journal of Headache|June 30, 2026
Efficacy of digital therapeutic sinCephalea for personalised nutrition versus control for migraine prevention: A 12-week open-label randomised clinical trialStefan Evers, Hanna C B Grube, Astrid Gendolla, et al.
Cephalalgia : an International Journal of Headache|June 30, 2026
Effectiveness and clinical predictors of rimegepant for acute vertigo in vestibular migraine: A real-world cohort studyYingqiang Li, Lingling Yu, Dongzhou Deng, et al.
Cephalalgia : an International Journal of Headache|June 19, 2026
Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohortEdoardo Caronna, Rut Mas-de-Les-Valls, Gabriella Egeo, et al.
Cephalalgia : an International Journal of Headache|June 25, 2026
Placebo or active comparator in chronic migraine trials: Balancing evidence and practicalityNancy van Veelen, Raffaele Ornello, Gisela M Terwindt, et al.
Cephalalgia : an International Journal of Headache|June 24, 2026
Impaired bone status in high frequency episodic or chronic migraine women: A case-control study with blood and densitometric parametersMarina Haro, María Muñoz-San Martín, Gabriel Gárate, et al.
Cephalalgia : an International Journal of Headache|June 24, 2026
Distribution of intranasal lidocaine and its effect on electrically-evoked calcium signals in mouse trigeminal ganglion neuronsLisa Tiebl, Hans Jürgen Solinski, Sara Belejova, et al.
Cephalalgia : an International Journal of Headache|July 27, 2026
Treatment patterns and Reasons for Discontinuing Preventive Treatment in Cluster Headache: A prospective cohort studyAnja Sofie Petersen, Sophie Bryde Laursen, Marie-Louise Kulas Søborg, et al.
Cephalalgia : an International Journal of Headache|July 16, 2026
Periaqueductal gray matter echogenicity: An irreversible marker of chronic migraine?Belén Flores-Pina, Dolores Vilas Rolán, José Ríos Guillermo, et al.
Cephalalgia : an International Journal of Headache|July 15, 2026
Prediction of migraine treatment response with clinical and genetic data: A machine learning analysis of the HUNT studyHåkon Kvisle Abildsnes, Antonios Danelakis, Samita Giri, et al.
Pageof 480